Liver Intensive Therapy Unit, King's College Hospital, London, UK.
Liver Failure Group, Division of Medicine, University College London, London, UK; Institute for Liver and Digestive Health, Division of Medicine, University College London, London, UK; Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK.
Lancet. 2015 Oct 17;386(10003):1576-87. doi: 10.1016/S0140-6736(15)00309-8. Epub 2015 Sep 27.
Acute-on-chronic liver failure combines an acute deterioration in liver function in an individual with pre-existing chronic liver disease and hepatic and extrahepatic organ failures, and is associated with substantial short-term mortality. Common precipitants include bacterial and viral infections, alcoholic hepatitis, and surgery, but in more than 40% of patients, no precipitating event is identified. Systemic inflammation and susceptibility to infection are characteristic pathophysiological features. A new diagnostic score, the Chronic Liver Failure Consortium (CLIF-C) organ failure score, has been developed for classification and prognostic assessment of patients with acute-on-chronic liver failure. Disease can be reversed in many patients, and thus clinical management focuses upon the identification and treatment of the precipitant while providing multiorgan-supportive care that addresses the complex pattern of physiological disturbance in critically ill patients with liver disease. Liver transplantation is a highly effective intervention in some specific cases, but recipient identification, organ availability, timing of transplantation, and high resource use are barriers to more widespread application. Recognition of acute-on-chronic liver failure as a clinically and pathophysiologically distinct syndrome with defined diagnostic and prognostic criteria will help to encourage the development of new management pathways and interventions to address the unacceptably high mortality.
急性慢性肝衰竭是指在患有慢性肝病的个体中发生的肝功能急性恶化,并伴有肝和肝外器官衰竭,且与较高的短期死亡率相关。常见的诱发因素包括细菌和病毒感染、酒精性肝炎和手术,但在超过 40%的患者中,并未发现诱发事件。全身性炎症和易感染是其特征性的病理生理学特征。一种新的诊断评分,即慢性肝衰竭联盟(CLIF-C)器官衰竭评分,已被开发出来,用于分类和评估急性慢性肝衰竭患者的预后。在许多患者中,疾病是可以逆转的,因此临床管理的重点在于识别和治疗诱因,同时提供多器官支持性护理,以解决患有肝病的重症患者复杂的生理紊乱模式。肝移植在某些特定情况下是一种非常有效的干预措施,但受者识别、器官可用性、移植时机和高资源利用等因素是其广泛应用的障碍。认识到急性慢性肝衰竭是一种具有明确诊断和预后标准的临床和病理生理学上不同的综合征,将有助于鼓励开发新的管理途径和干预措施,以解决不可接受的高死亡率问题。